Caribou Biosciences
cariboubio.comLocations
United States · Berkeley, CA, USA · San Francisco, CA, USA · North America
industry
Health · Biotechnology · DeepTech
Size
51-200 employees
Stage
IPO
founded in
2011
Caribou Biosciences is a operator of a medical technology company intended to analyze cell and genome engineering. The company specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling development of therapeutics for agricultural biotechnology, industrial biotechnology and basic and applied biological research.
Something looks off?Open jobs at Caribou Biosciences